Facebook
Twitter
LinkedIn
Forward
Akkermansia muciniphila, a key player in the gut microbiome, has emerged as a significant influencer of GLP-1, a hormone with profound implications for metabolic health.
|
Nutrition is one of the pillars of obesity treatment. While clinicians are easily able to advise patients what NOT to eat, telling patients what to eat can be harder.
|
Youth with special healthcare needs are at increased risk for obesity and associated co-morbidities.
|
In this webinar, we will focus on deepening attendees understanding of the pathophysiology, diagnosis, and treatment of various comorbidities associated with childhood obesity. Dr.
|
Join us for an in-depth webinar designed for clinicians and scientists, exploring the intricate relationship between the gut microbiome and obesity.
|
In th
|
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
|
The 2024 Obesity Medicine Association (OMA) Annual Business Meeting hosted by Lydia Alexander, MD, MFOMA, President of the OMA.
|
This session will provide a practical guide to understanding and interpreting continuous glucose monitoring (CGM) data for healthcare providers managing patients with diabetes and obesity.
|
Discover how optimizing sleep can transform obesity medicine care and improve weight management outcomes.
|